Review: gut microbiota–inflammageing axis and diet in older adults' cardiometabolic health
This review abstract links age-related gut microbiota changes to low-grade inflammation and cardiometabolic disease in older adults, and appraises dietary strategies such as Mediterranean, Green-Mediterranean and plant-based patterns and intermittent fasting as modifiable entry points. [1]
Automatic summary · not editorially reviewed
The key findings
The abstract describes inflammageing as chronic, low-grade, sterile inflammation accompanying advancing age and shared across cardiovascular disease, metabolic syndrome and type 2 diabetes in older adults. [1]
TMAO is implicated in accelerating atherosclerosis, foam-cell formation and platelet reactivity, largely on the basis of rodent studies and observational human data. [1]
The abstract lists translational limitations including no standardised microbiome analytical pipelines, strain-specific heterogeneity of probiotic effects and no formal recommendations in current cardiovascular and diabetes guidelines. [1]
The source at a glance
- Study type / format
- Narrative-style review abstract synthesising mechanistic and clinical evidence
- Population / context
- Older adults, with a focus on cardiometabolic health; non-Western populations are noted as under-represented in research.
- Summary based on
- Study abstract
- Original publication
- September 22, 2026
Age-related dysbiosis and the leaky gut pathway
The abstract describes inflammageing as chronic, low-grade, sterile inflammation accompanying advancing age, shared across cardiovascular disease, metabolic syndrome and type 2 diabetes in older adults. With advancing age, beneficial taxa such as Bifidobacterium and Faecalibacterium prausnitzii are said to decline while pro-inflammatory taxa expand. This dysbiosis is described as compromising tight-junction integrity, producing a "leaky gut" phenotype that permits translocation of lipopolysaccharide and other pathogen-associated molecular patterns into the portal circulation. The resulting metabolic endotoxaemia is said to activate TLR4/NF-κB signalling and sustain systemic elevations of IL-6, TNF-α and IL-1β, converging on insulin resistance, endothelial dysfunction, oxidative stress and vascular injury. These are described mechanisms, not demonstrated causal effects in this abstract.
Supporting source [1]
TMAO, short-chain fatty acids and dietary patterns
Microbiota-derived metabolites are said to shape this trajectory. Trimethylamine-N-oxide (TMAO) is implicated in accelerating atherosclerosis, foam-cell formation and platelet reactivity, largely on the basis of rodent studies and observational human data. Short-chain fatty acids are described as reinforcing barrier function and inducing regulatory T cells. The review abstract states that Mediterranean, Green-Mediterranean and plant-based dietary patterns, together with intermittent fasting, have been shown to remodel the gut microbiota, reduce systemic inflammatory tone and improve cardiometabolic risk profiles. Named dietary components are fibre-derived short-chain fatty acids, polyphenols and their microbial metabolites, omega-3 polyunsaturated fatty acids with specialised pro-resolving mediators, and age-appropriate protein intake.
Supporting source [1]
Translational limits, safety notes and research gaps
Emerging approaches examined include precision nutrition guided by individual microbiome profiles, next-generation probiotics, prebiotics and postbiotics, and small-molecule inhibitors targeting TMAO biosynthesis. The abstract lists current translational limitations: no standardised microbiome analytical pipelines, strain-specific heterogeneity of probiotic effects, and no formal recommendations in current cardiovascular and diabetes guidelines. Safety considerations for frail older adults are highlighted: hypoglycaemia risk during intermittent fasting, bleeding risk with high-dose omega-3 supplementation, and rare bacteraemia associated with probiotic use in immunocompromised individuals. Research gaps named are scarce long-term follow-up, under-representation of non-Western populations and heterogeneity across ageing stages. The review is presented as a theoretical foundation for individualised nutritional strategies, not as established clinical guidance.
Supporting source [1]
How to interpret this
This explainer is based only on the abstract; the full text was not reviewed. The abstract reports no primary study design, sample size, follow-up or outcome data of its own, and several mechanistic links rest on rodent studies and observational human data. Associations described are not established causes, and the dietary and probiotic approaches are not presented as formal recommendations.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Liu X, Huang S, Liu JQ, Wang SN, Pang TX, Wang QF. · europepmc.org · September 22, 2026